Astrazeneca Pharma India falls; Sebi says exchanges to monitor delisting

Tags: Companies
Shares in Astrazeneca Pharma India Ltd fell 3 percent after the SEBI on Tuesday said stock exchanges will closely monitor the company's delisting process and promptly report any aberrations.

"The promoters of M/s Astrazeneca Pharma India Ltd. shall finally purchase shares from public shareholders in the delisting offer only after seeking approval of the Bombay Stock Exchange Limited and National Stock Exchange Limited," added the Securities and Exchange Board of India in an order.

The regulator also said it came across certain reports that the offer for sale (OFS) of the shares of Astrazeneca Pharma India Ltd carried out by its promoter AstraZeneca Pharmaceuticals AB Sweden on May 26, 2013 was a deliberate attempt to subsequently get the shares of the Indian unit delisted at ease.

It was also reported that more than 94 percent of total shares offered through OFS had been subscribed by six foreign institutional investors including DB International Asia Ltd, Suffolk (Mauritius), Morgan Stanley Asia (Singapore) PTE, BNP Paribas Arbitrage, Manfield (Mauritius) Ltd and Merrill Lynch Capital Markets Espana S.A. SVB.

EDITORIAL OF THE DAY

  • India is yet to play fair with her women sportspersons

    Women in India make news when their being women for better or worse is the reason, not because their achievements single them out as persons who have

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Amita Sharma

Surely, our children deserve the best?

The findings of the latest national achievement survey for Class ...

Zehra Naqvi

It’s only words

The Indian film industry is, perhaps, the most recognisable symbol ...

Bubbles Sabharwal

Ruling the world from the kitchen

Today I am one thing, tomorrow another! Sometimes wife, sometimes ...